Oramed Pharmaceuticals
ORMP
#9140
Rank
A$0.25 B
Marketcap
A$5.81
Share price
0.51%
Change (1 day)
62.35%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2026 (TTM): A$95.26 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of A$92.35 Million, an increase over its 2024 earnings that were of -A$22.36 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$95.26 M3.16%
2025 A$92.35 M-513.21%
2024 -A$22.36 Million-311.47%
2023 A$10.56 M-119.45%
2022 -A$54.34 Million39.17%
2021 -A$39.05 Million73.93%
2020 -A$22.45 Million18.53%
2019 -A$18.94 Million-16.62%
2018 -A$22.72 Million38.32%
2017 -A$16.42 Million12.51%
2016 -A$14.6 Million25.01%
2015 -A$11.68 Million18.18%
2014 -A$9.88 Million39.72%
2013 -A$7.08 Million46.4%
2012 -A$4.83 Million128.32%
2011 -A$2.12 Million-51.47%
2010 -A$4.36 Million35.21%
2009 -A$3.23 Million
2007 -A$5.07 Million607.04%
2006 -A$0.72 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novo Nordisk
NVO
A$34.09 B 36,485.33%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
A$11.55 B 12,296.78%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-A$0.67 Billion-811.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-A$90.67 Million-197.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
A$51.74 M-44.47%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel